UK Companies House feature
VERAMED LIMITED
Cash
£3M
+159.1% vs 2019
Net assets
£5M
+71.2% vs 2019
Employees
70
+40% vs 2019
Profit before tax
—
Period ending 2020-12-31
Profile
- Company number
- 07195346
- Status
- Active
- Incorporation
- 2010-03-19
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 62020
Net assets
2-year trend · vs UK AI & Enterprise SaaS median
Accounts
2-year trend · latest 2020-12-31
| Metric | Trend | 2019-12-31 | 2020-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | — | — | |
| Profit before tax | — | — | |
| Net profit | — | — | |
| Cash | £966,513 | £2,503,974 | |
| Total assets less current liabilities | — | — | |
| Net assets | £3,119,613 | £5,340,488 | |
| Equity | £3,119,613 | £5,340,488 | |
| Average employees | 50 | 70 | |
| Wages | — | — |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Crowe U.K. LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors consider the going concern basis to be appropriate having paid due regard to the company's projected results during the twelve months from the date the financial statements are approved and the anticipated cash flows, availability of loan facilities and mitigating actions that can be taken during that period. Furthermore, the company has received confirmation from Matrix 2021 Holdings Limited that it will support the company for a period of at least twelve months from the date of approval of these financial statements, including the non-recall of amounts owed to group undertakings.”
Subsidiaries
- Veramed Ukraine LLC · 100% held · Ukraine
- Veramed Inc. · 100% held · USA
- Veramed GmbH · 100% held · Germany
- Veramed Data Services Private Limited · 100% held · India
- Veramed Arrow US Inc. · 100% held · USA
- Clinical Data Trial Services, LLC · 100% held · USA
- Veramed Canada Ltd. · 100% held · Canada
- Veramed Shannon Inc. · 100% held · USA
- BioPier, LLC · 100% held · USA
Significant events
- “The company has operations in Ukraine.”
- “The company's future challenges include the successful integration of acquired companies, continued commercial and operational expansion in the US and India, and maintaining a strong employee value proposition globally as the company continues to grow.”
- “There have been no significant events affecting the company since the year end.”
- “No significant post balance sheet events affecting the company have been identified.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
7 active · 0 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| CHHOA-WILSON, Charles Guy | Director | 2020-03-02 | Nov 1978 | British |
| HUTCHINSON, Katherine | Director | 2022-06-20 | Dec 1964 | British |
| JONES, Emma Louise, Dr. | Director | 2016-09-01 | Sep 1980 | British |
| JONES, Matthew Peter Andrew | Director | 2010-03-19 | Jun 1977 | British |
| MCGUIRE, Stuart | Director | 2020-03-02 | Jun 1976 | British |
| RYALLS, Daniel Lee | Director | 2024-07-01 | Jul 1974 | British |
| SEYMOUR, Thomas Michael | Director | 2022-12-20 | Feb 1983 | British |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mrs Emma Louise Jones | Individual | Shares 25–50%, Voting 25–50%, Appoints directors | 2021-03-02 | Ceased 2021-10-26 |
| Matrix 2021 Bidco Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2020-10-26 | Active |
| Mr Matthew Jones | Individual | Shares 25–50%, Voting 25–50%, Appoints directors | 2016-04-06 | Ceased 2021-10-26 |
Filing timeline
Last 20 of 70 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-05-01 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-06-03 | AA | accounts | accounts with accounts type full |
| 2025-05-09 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2025-04-28 | CS01 | confirmation-statement | confirmation statement with updates |
| 2024-07-30 | AP01 | officers | appoint person director company with name date |
| 2024-07-16 | CH01 | officers | change person director company with change date |
| 2024-07-12 | CH01 | officers | change person director company with change date |
| 2024-07-08 | AA | accounts | accounts with accounts type full |
| 2024-05-03 | CS01 | confirmation-statement | confirmation statement with updates |
| 2024-04-30 | SH01 | capital | capital allotment shares |
| 2024-03-12 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2024-02-21 | PSC05 | persons-with-significant-control | change to a person with significant control |
| 2023-12-14 | SH01 | capital | capital allotment shares |
| 2023-10-12 | MR01 | mortgage | mortgage create with deed with charge number charge creation date |
| 2023-06-13 | AA | accounts | accounts with accounts type full |
| 2023-04-26 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-12-20 | AP01 | officers | appoint person director company with name date |
| 2022-09-26 | AA | accounts | accounts with accounts type full |
| 2022-06-30 | AP01 | officers | appoint person director company with name date |
| 2022-04-21 | CS01 | confirmation-statement | confirmation statement with no updates |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory